As an independent platform in operation for more than a year with stellar accuracy, we have become a trusted niche publisher for market leaders, including fund managers, analysts, biopharma executives, policy makers as well as the everyday investors. Nearly all companies that we featured appreciated by several folds, thus, helping to unlock substantial value for shareholders as well as to help with capital financing. Stellar firms under our featured coverage often get acquired by larger biopharma. Please contact us at 704-953-9388 to consult whether your firm qualifies for our feature coverage.
If you can write and have a strong background, taking money from readers are not difficult. Nonetheless, the big picture is whether you are happy with yourself for doing so.
Anh học ngôn ngữ, không từ trường lớp mà do hơi thở tận đáy tim anh. Anh tặng em bài viết tốt nghiệp này, mong sao cho tương lai mang lại nghề nghiệp và đời sống tốt đẹp cho ta nói riêng và mọi người nói chung.
Như một thủa ngàn thu, anh ít khi nào anh giải thích những gì mình làm vì anh không muốn mất đi ý nghĩa riêng của nó, nhưng để anh chia sẽ với em. Anh ăn vạ, chứ không phải ăn xin, hoạc ăn thua đủ; và anh cũng chả thua thầy nào, to hay nhỏ. Đàn ông muốn làm những gì ý nghĩa, phải có bản lãnh, chịu được cực khổ và biết khiêm nhường. Vì vậy, anh trước giờ, không nhận giúp đỡ hoạc muốn mang ơn ai, chứ không phải không có người tốt giúp.
While it is seemingly easy to be fearful, seeing your stocks drops like as if the is recession coming coupled with the fact that Wall Street bulls are having the biggest feasts of their lifetime, the intelligent investors might ask, when is the bull market is going to end. I can not help but remember the famous line Warren Buffett quoted from Barton Biggs, "A bull market is like sex, it feels best just before it ends."
Editor Notes: This is a draft in progress. We will update approach and new insight going forward.
Have you ever wonder why there are certain medical conditions and promising therapy that are in developments for decades yet to end up in repetitive disappointment? That is seemingly the case for a medical condition known as multiple sclerosis (MS) and gene therapy. In this paper, we seek to provide an overview of MS and to propose a specific way we can cure it.
Causes and symptoms
Believed to be caused by the body's natural defense systems against diseases that attacks the myelin wrapping on neurons in the back of our spinal cord, MS affiliated mostly caucasians. Most of the patients exhibit symptoms, such as muscle weakness, optic neuritis, double vision, unsteady gait, and a feeling of numbness as well as tingling.
When most of us are growing up and are expecting to have a fairy tale love story with our Prince Charming or model princess to scoop us up into a happily ever after family, the reality is that the opposite tend to occur. Many end up marrying to someone that they do not truly love or to have to settle with those that are not their top choice that is their soul mate.
In reflecting about what's gone down last year and in my life in general, I feel like nearly all people that I fought for with my heart and soul broke my heart. Needless to say, I'm still loyal to this day. I am not blaming anyone. C'est la vie.
Editor Notes: We will continue to update and expand on the research as time permits, to help readers gain a more comprehensive picture regarding the firm. We do not endorse this company but we are conducting further research and wish to share our notes with readers. It is important to conduct thorough research when deciding to purchase a new biopharma with a small cap that that has to make profits.
BioDelivery Sciences (Nasdaq:BDSI), a Raleigh NC based firm, that focuses on pain addiction medicine, announced the onboard of former Salix Pharmaceuticals Head of Sales Mr. Plesha. With more than 25 years of sales experience and 18 years of sales management in the biopharma and medical industry, Plesha will be an invaluable asset to push forward sales of lead drug Bunavail that is used to treat opioid dependence.
Source: BioDelivery Sciences
Editor notes: T2 Biosystem has a revolutionary technology, T2MR, but it has not catch on to mainstream medicine, thus, making the business to absorb profits loss for now. With time and awareness, the technology can be a big hit in the medical arena.
In the world of medical diagnostic, delivering the test results for certain condition like blood bacteria an hour early can means the difference between life and death. To feed the need that saves lives, T2 Biosystems (Nasdaq:TTOO), a Lexington Massachusetts based firms, is delivering the stellar diagnostic technology that beats the clock by days.
The crown jewel revolutionary diagnostic, T2MR technology, leverages on the responses of water molecules in a magnetic field to yield beautiful and insightful imaging.
- The MD-360 Report: Buy low. Buy value. Buy panic. Buy MLPs.
- Catching Shares with Dr. Tran: An Analysis of Bluebird Bio's HIV Lentiviral Vector
- A Letter to the Heart That Mattered Most
- The MD-360 Report: BioDelivery Sciences Delivers Strong Second Quarter 2015 Financial Results
- Catching Share with Dr. Tran: To My Wife the 360 Bull Tammy Pham
- The MD-360 Report: An Elucidation of Cyclical Companies, Featuring Cliffs Natural Resources
- Catching Shares with Dr. Tran: How to Increase Your Longevity
- The MD-360 Report: A Rare Investment Opportunity with Encore Vineyards Ltd.
- Relationship Education: Be Generous with Your Heart and Apology
- Catching Shares with Dr. Tran 3/365: Why Natural Health Trends is Stellar Growth Company?
- Catching Shares with Dr. Tran 2/365: How to Invest and Trade Stocks Intelligently?
- Catching Shares with Dr. Tran: Why Apple is Now a Stellar Bargain Buying Opportunity?
- Catching Shares with Dr. Tran: Healthy and Easy to Cook Foods
- Catching Shares with Dr. Tran: Real Hopes for Cryonics
- Catching Shares with Dr. Tran 1/365: Elucidating the Investing Thesis on Amicus Therapeutics
- Catching Shares with Dr. Tran: Debriefing and Reflecting
- Catching Shares with Dr. Tran: Streetballing and Having Fun
- Catching Shares with Dr. Tran: 21 Game Work Out
- Catching Shares with Dr. Tran: Skateboard to Jump Higher
- Catching Shares with Dr. Tran: Regulating Street Ball
- Amicus Therapeutics: Why It's Time to Fold Amicus?
- Catching Shares with Dr. Tran: Brief Commentary on Insider Trading Violation
- Catching Shares with Dr. Tran: Biotech Stocks Manipulation Part II
- Catching Shares with Dr. Tran: Biotech Stocks Manipulation Part I
- Catching Shares With Dr. Tran: Gardening, Being And Protecting The Earth Tesla
- Catching Shares With Dr. Tran: Healthy Vegetarian Foods And Less Poisons From Biopharma
- Catching Shares With Dr. Tran: An Inquiry Into Human Nature And The Essence of Freewill
- Investing Education: What Are Market Bulls And Bears?
- Catching Shares (Xe) With Dr. Tran: Is It Ironic That Clowns Are Educating Professionals?
- Catching Shares With Dr. Tran: Shortcuts Your Morality And Life Will Cut You
- Catching Shares With Dr. Tran: Visiting The Old Days Street Ball Court
- Why Bluebird Bio Uses of HIV For Gene Therapy is Dangerous?
- UniQure NV: Is It Worth It?
- Vertex Pharmaceuticals: Is It Worth It?
- Sarepta Therapeutics: Is It Worth It?
- Catching Shares With Dr. Tran: Một Chút Suy Gẫm Trong Cuộc Sống
- What Investors Can Expect From Natural Health Trends Earnings Report
- Catching Shares With Dr. Tran: An Inquiry Into The Relativity of Truth That Is Life
- Catching Shares With Dr. Tran: Không Thầy Có Mày Làm Nên?
- AcelRx Pharmaceutical Inc: Zalviso Receives Positive Opinions from CHMP But Questions Remained
- 2016 Presidential Candidates: Hillary Clinton Trumps Donald Trump By Far
- Navios Maritime Continues to Pay Strong Dividend Amidst Market Downtrend
- The MD-360 Report: Could AntriaBio Delivers The Knockout Punch for Diabetes Treatment?
- Catching Shares With Dr. Tran: Unlocking Sequence to Galvanize Victor Frankenstein
- The MD-360 Report: Acute Mountain Sickness and Environment-Induced Genes Expression Part I